Safety, tolerability, pharmacokinetics and pharmacodynamics of the oral cyclin-dependent kinase inhibitor AZD5438 when administered at intermittent and continuous dosing schedules in patients with advanced solid tumours

  1. Lookup NU author(s)
  2. Professor Alan Calvert
  3. Professor Ruth Plummer
Author(s)Boss DS, Schwartz GK, Middleton MR, Amakye DD, Swaisland H, Midgley RS, Ranson M, Danson S, Calvert H, Plummer R, Morris C, Carvajal RD, Chirieac LR, Schellens JHM, Shapiro GI
Publication type Editorial
JournalAnnals of Oncology
Year2010
Volume21
Issue4
Pages884-894
ISSN (print)0923-7534
ISSN (electronic)1569-8041
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
PublisherOxford University Press
URLhttp://dx.doi.org/10.1093/annonc/mdp377
DOI10.1093/annonc/mdp377
Actions    Link to this publication
Share